Silica nanomatrix enhances immunotherapy for solid tumors
Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of…
Study reveals a therapeutic vulnerability in aggressive subtype of triple-negative breast cancer
Dec 26 2025 A new study published today in Science Translational Medicine by researchers at The University of…
Opioid receptor agonists take advantage of new understanding of GPCR biology
 Opioid receptors are fantastic targets for treating pain—but unfortunately, the drugs that target them can be addictive.…
Blocking platelet-activating factor reduces liver damage in cirrhosis
Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural…
How diabetes medications may influence cancer risk and progression
Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver,…
Cryo-EM reveals NPFFR1 activation and guides novel ligand design
This study investigates the molecular mechanisms underlying ligand recognition, subtype selectivity, and activation of neuropeptide FF receptor 1…
Exploring melatonin therapeutic potential in systemic lupus erythematosus
A recent review published in Current Molecular Pharmacology explores the therapeutic potential of melatonin in systemic lupus erythematosus…
New findings show why the human intestine uniquely presents gluten to T cells
New evidence shows that human M cells act as fully fledged antigen-presenting cells, processing and presenting gluten peptides…
Glucose-lowering drugs may reduce risk of developing epilepsy
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to…
Gut microbe metabolite TMA improves blood sugar by shutting down a key inflammatory switch
A microbial metabolite long linked to cardiovascular risk emerges as a surprising ally against metabolic inflammation, revealing how…
Study shines light on how P2X4 receptor can be inhibited
A study carried out by the University of Bonn and the University Hospital Bonn throws light on how…
Diabetes drugs linked to slower frailty progression in older adults
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2)…